What Is the Cheapest GLP-1 Without Insurance?

Without insurance, the monthly cost of GLP-1 treatment runs from a few hundred dollars for compounded versions to well over a thousand for branded pens. This page ranks the main options by the approximate US list prices used across this site, cheapest first, with the caution attached to each one, because the lowest sticker price is never the whole story.

Prescription medicine boxes and a calculator on a table with a receipt

The ranking, cheapest first

The figures below are the approximate US list prices for the branded medicines and typical advertised starting prices for the compounded versions, the same figures used in the GLPKit cost tools. Real quotes vary by pharmacy, dose and provider, so read this as an ordering, not a quote.

OptionApproximate price per monthThe short version
Compounded semaglutideAbout $249Pharmacy made version of the Ozempic ingredient. Not FDA approved.
Compounded tirzepatideAbout $379Pharmacy made version of the Mounjaro ingredient. Not FDA approved.
Ozempic (semaglutide)About $1,000Branded pen, FDA approved for type 2 diabetes.
Zepbound (tirzepatide)About $1,060Branded, FDA approved for weight management.
Mounjaro (tirzepatide)About $1,080Branded pen, FDA approved for type 2 diabetes.
Wegovy (semaglutide)About $1,350Branded pen, FDA approved for weight management.

One thing the table cannot show: these medicines are not interchangeable line items. Ozempic and Mounjaro are approved for type 2 diabetes, while Wegovy and Zepbound are approved for weight management, and a prescriber weighs the medical fit first. The ranking answers the cost question only. The GLP-1 cost without insurance hub explains the branded prices and why quotes vary.

Why compounded versions top the list, and the caution attached

The two cheapest rows are not the branded product at a discount. Compounded versions are prepared by compounding pharmacies for individual prescriptions. They are not FDA approved, the finished product is not reviewed for safety, effectiveness or manufacturing quality the way a branded pen is, and quality and dosing can vary between pharmacies. The FDA has published cautions about dosing errors, salt forms of the ingredient and counterfeit products in this market. Our compounded semaglutide guide explains all of that in detail. The advertised figures are also starting prices: the monthly total commonly rises with dose, and many services add consultation or membership fees on top.

Cheapest is not automatically best

Four questions matter alongside price. First, approval and oversight: a branded pen is an FDA approved product with a fixed dosing system, and a compounded vial is not. Second, medical fit: the approved uses differ, and your own conditions and other medicines shape which drug a prescriber will choose. Third, continuity: treatment usually runs for many months, so a supplier you may have to leave, or a rule change that cuts off supply, has a real cost. Fourth, the honest total: consultations, follow up, syringes or program fees can narrow the gap between rows. The GLP-1 cost calculator and the compounded savings calculator let you run the branded and compounded figures side by side over the number of months you choose.

Ways the real price comes down

The sticker ranking is a starting point, not the final bill. Manufacturer savings cards reduce what commercially insured patients pay, although they generally require commercial insurance and cannot be used with government insurance such as Medicare or Medicaid. Manufacturer patient assistance programs exist for people who meet the program rules, which the manufacturers set and verify. Cash prices for the same pen also vary between pharmacies, so the pharmacy you choose changes the branded rows. The guide to getting a GLP-1 without insurance walks through each route in order.

Frequently asked questions

What is the cheapest GLP-1 without insurance?

By the approximate prices used on this site, compounded semaglutide is the cheapest route, with advertised starting prices around $249 a month, followed by compounded tirzepatide at around $379. The cheapest branded pen by list price is Ozempic at about $1,000 a month, although Ozempic is approved for type 2 diabetes rather than weight management. Compounded products are not FDA approved, so the price gap comes with real cautions.

Why are compounded GLP-1 medicines so much cheaper?

Compounded versions are made by compounding pharmacies for individual prescriptions rather than manufactured as finished branded products. They do not go through FDA approval, and their advertised prices are starting prices that can rise with dose and program fees. The lower price reflects a different product and a different level of oversight, not the same pen at a discount.

Is the cheapest GLP-1 the best choice?

Not automatically. The right medicine depends on your diagnosis, your other conditions and what your prescriber judges safest and most effective for you. Approval status, dosing accuracy and continuity of supply also matter. Price is a legitimate part of the decision, but it works best as the second question, after the medical one.

Can the price I am quoted differ from this list?

Yes. Branded list prices are approximate, and cash quotes vary by pharmacy, dose and package size. Compounded prices vary by provider, dose and program fees. Always confirm the current total, including any consultation or membership charges, before you commit to a supplier.

Can I start on one GLP-1 and switch to a cheaper one later?

Switching happens, but it is a prescriber decision. The medicines have different dose schedules and approved uses, so a switch usually means a new prescription and a fresh dose build up period. Do not switch products or adjust doses on your own in order to save money.

Sources. List prices on this page are the approximate US list prices and typical advertised starting prices used consistently across the GLPKit cost tools and guides. They are reference points, not quotes, and pharmacies and providers set their own prices. Approved uses follow the FDA approved prescribing information published on DailyMed by the U.S. National Library of Medicine. Compounding cautions follow the FDA's public information on compounded GLP-1 products.
Educational information only. Prices on this page are approximate US list prices or typical advertised starting prices at the time of writing. They vary by pharmacy, dose, presentation and program terms, and they change. This page is not medical or financial advice, and GLPKit does not sell medicines or process prescriptions. Confirm any price or program detail with the pharmacy, your plan or the manufacturer before relying on it.

Back to all GLPKit guides